Read + Share
Matsui Y, Yamada T, Katayama Y, Hirai S, et al. Initial AXL and MCL-1 inhibition contributes to abolishing lazertinib tolerance
in EGFR-mutant lung cancer cells. Cancer Sci 2024 Jul 22. doi: 10.1111/cas.16292.
PMID: 39039802
|
 |
|
Matsui Y, Yamada T, Katayama Y, Hirai S, et al. Initial AXL and MCL-1 inhibition contributes to abolishing lazertinib tolerance
in EGFR-mutant lung cancer cells. Cancer Sci 2024 Jul 22. doi: 10.1111/cas.16292.
PMID: 39039802
|
|
|
|